Alterity Therapeutics Limited
ATH
Clasificación en acciones
#25694
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Precio por acción
$0.20453259
Capitalización bursátil
$44.69M
Cambio (1 día)
1.75%
Cambio (1 año)
-41.56%
País
AU
Comercio Alterity Therapeutics Limited (ATH)
Categoría
Healthcare
EPS de Alterity Therapeutics Limited (ATH)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Alterity Therapeutics Limited, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Alterity Therapeutics Limited desde 2026 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| - | - |
CH
|
|
| $27.74 | - |
NL
|
